What Is SUV — on a PET Scan?

No. Many conditions produce an elevated SUV, including active infection, inflammation, recent surgery, healing tissue, and some benign tumours. The brain has a naturally high SUV because it depends heavily on glucose. Your radiologist accounts for all of this when interpreting the scan, and your oncologist weighs the figure against everything else known about your case. A high number in isolation is not a diagnosis.

The most useful question is not whether the number is high or low — it is what the number means for your specific situation. Ask your oncologist: how does this compare with the last scan, what does it suggest about how the cancer is behaving, and does it change the plan? A number without context is not a verdict, and your team has that context.

In many cases, a fall in SUV on a repeat scan is one sign that the cancer is responding to treatment. EANM and SNMMI guidelines describe criteria for what counts as a meaningful change based on SUV. Whether a change in your own scan is meaningful depends on how large the change is, which treatment you are on, and your cancer type — your oncologist will interpret it in that full context.

There is no single normal value. Different organs have different baseline uptake — the brain and heart absorb far more tracer than most other tissues. What matters is whether the uptake in a specific area is higher than expected for that organ, and how it compares with your previous scans. Your radiologist knows the expected range for each region and flags areas that fall outside it.

A lower SUV on a follow-up scan is generally the direction your team hopes to see, particularly during or after treatment. But the interpretation depends on how large the change is, the organ involved, and the reason the scan was done. Small changes can fall within normal scan-to-scan variation. Discuss the comparison directly with your oncologist, who will put the change in the context of your full picture.

Not meaningfully. The same SUV in the same organ can behave very differently in two people, depending on the biology of the tumour, the equipment used, and the time between tracer injection and scanning. Guidelines from EANM recommend standardised protocols precisely because these variables affect the number. Your SUV is only meaningful compared with your own earlier scans, done under similar conditions.